Results for tag: "Zelboraf"

Zelboraf (vemurafenib) is a targeted therapy drug used to treat advanced melanoma, a type of skin cancer. It is a kinase inhibitor, meaning it works by blocking certain proteins that help cancer cells grow and divide. Zelboraf is used in combination with other drugs to treat advanced melanoma that has spread to other parts of the body. It is also used to treat melanoma that has returned after surgery. The Zelboraf market is a rapidly growing segment of the skin cancer drug market. It is estimated that the global market for skin cancer drugs will reach $7.5 billion by 2027. Zelboraf is one of the most widely used drugs in this market, and is expected to remain a key player in the years to come. Some of the major companies in the Zelboraf market include Genentech, Novartis, Merck, and Bristol-Myers Squibb. These companies are actively researching and developing new treatments for skin cancer, as well as marketing and distributing existing treatments. Show Less Read more